Skip to content

Why Healthcare ETFs Like XLV Remain a Safe Bet in Volatile Markets

When tech stocks falter, savvy investors turn to healthcare for resilience. Discover how XLV balances risk and reward in an ever-changing economic landscape.

The image shows an infographic poster with text and images that reads "Investing in America" and...
The image shows an infographic poster with text and images that reads "Investing in America" and provides information about the various industries that are investing in the United States. It includes details such as the number of jobs available, the types of investments available, and the estimated time it takes to invest in each industry. The poster also includes visuals such as graphs and charts to help illustrate the data.

Why Healthcare ETFs Like XLV Remain a Safe Bet in Volatile Markets

The healthcare sector remains a key player in the S&P 500, ranking as the sixth-largest by market size. Investors often turn to this industry during periods of uncertainty, particularly when tech stocks lose momentum. One popular way to gain exposure is through the Health Care Select Sector SPDR Fund (XLV), an ETF tracking all healthcare stocks in the index. XLV holds a broad range of healthcare companies, weighted by their market value. The fund covers three major subsectors: medical devices, health insurance, and pharmaceuticals. Each faces distinct challenges—device makers struggle with tighter margins due to rising long-term interest rates, while insurers contend with shifting regulations, corporate benefits, and government reimbursement policies.

Pharmaceutical firms, however, benefit from strong patent protections and steady global drug spending. Artificial intelligence could further boost their profits by accelerating drug discovery and cutting costs. Despite these dynamics, XLV maintains a reputation for stability, with a beta of just 0.58—far lower than the broader market. Currently, the ETF trades at under 18 times trailing earnings, a valuation that appears modest given the sector’s vast, multitrillion-dollar demand. Analysts like Rob Isbitts have developed tools, such as the ROAR Score, to help individual investors assess risk and build diversified portfolios. XLV often serves as a defensive choice when market turbulence rises and tech-driven growth slows.

XLV offers investors a way to tap into a resilient sector with lower volatility than many alternatives. Its valuation remains attractive relative to the healthcare industry’s long-term demand. For those seeking stability amid shifting market conditions, the fund continues to be a widely considered option.

Read also:

Latest